Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical tranexamic acid for wound healing after facial basal cell carcinoma excision
IRCT20260412069054N1Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial of tranexamic acid in basal cell carcinoma (BCC) (2 arms), sponsored by Mashhad University of Medical Sciences. Primary endpoint: Postoperative ecchymosis. Started Apr 2026; status: completed.
02
Drugs
tranexamic acid
03
Conditions
basal cell carcinoma (BCC)
Beyond the preview
Go deeper on IRCT20260412069054N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20260412069054N1.